Literature DB >> 4869773

[Cardiac complications observed during treatment with rubidomycin].

C Macrez, H Marneffe-Lebrequier, J Ripault, J P Clauvel, C Jacquillat, M Weil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4869773

Source DB:  PubMed          Journal:  Pathol Biol


× No keyword cloud information.
  9 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

Review 2.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Daunorubicin. Results in childhood leukaemia.

Authors:  R N Matthews; J H Colebatch
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

4.  Daunomycin: a cardiotoxic agent.

Authors:  L E Ainger; J Bushore; W W Johnson; J Ito
Journal:  J Natl Med Assoc       Date:  1971-07       Impact factor: 1.798

5.  [Toxic side effects of daunomycin in children].

Authors:  L Massimo
Journal:  Blut       Date:  1970-01

Review 6.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

7.  Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts.

Authors:  E Bachmann; E Weber; G Zbinden
Journal:  Agents Actions       Date:  1975-10

8.  Damage to the intrinsic cardiac neurones by rubidomycin (daunorubicin).

Authors:  B Smith
Journal:  Br Heart J       Date:  1969-09

9.  Clinical evaluation of adriamycin, a new antitumour antibiotic.

Authors:  G Bonadonna; S Monfardini; M De Lena; F Fossati-Bellani
Journal:  Br Med J       Date:  1969-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.